Takeda reaches preliminary agreement to buy Shire for $65bn via @FT https://t.co/vXj7Eiid7H — The Propell Group (@ThePropellGroup) April 25, 2018
A frenzy of dealmaking in pharma points to cost pressure via @FT https://t.co/OBxKxmD024 — The Propell Group (@ThePropellGroup) April 25, 2018
3 challenges Apple faces in path to widespread adoption of health record feature https://t.co/T7vPghf5y3
0 0
3 challenges Apple faces in path to widespread adoption of health record feature https://t.co/T7vPghf5y3 — The Propell Group (@ThePropellGroup) April 24, 2018
Ping An Good Doctor starts preparing $1.1 billion Hong Kong IPO https://t.co/KCvGkXsTyw via @business
0 0
Ping An Good Doctor starts preparing $1.1 billion Hong Kong IPO https://t.co/KCvGkXsTyw via @business — The Propell Group (@ThePropellGroup) April 23, 2018
CureFit in talks to raise %2475 million in funding https://t.co/kptW412ubM — The Propell Group (@ThePropellGroup) April 23, 2018
https://t.co/M9Q92h7tsY — The Propell Group (@ThePropellGroup) April 21, 2018
https://t.co/gCU7xdwfi4 — The Propell Group (@ThePropellGroup) April 21, 2018
UK small caps hope to help big pharma cut R&D costs via @FT https://t.co/jjMlq9z8ef — The Propell Group (@ThePropellGroup) April 21, 2018
Takeda sweetens offer for rival Shire to £42.8bn via @FT https://t.co/IrvgdndVB0 — The Propell Group (@ThePropellGroup) April 21, 2018
https://t.co/NNnNEl4cOR — The Propell Group (@ThePropellGroup) April 20, 2018